James W. Sharpe
Profile
James W.
Sharpe was President and Chief Executive Officer of Astralis Ltd.
He received an MBA from the University of Rochester and a BS degree from Union College.
Former positions of James W. Sharpe
| Companies | Position | End |
|---|---|---|
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | President | 2006-01-24 |
Training of James W. Sharpe
| Rochester Christian University | Masters Business Admin |
| Union College (New York) | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
- Stock Market
- Insiders
- James W. Sharpe
